loading
前日終値:
$15.88
開ける:
$15.76
24時間の取引高:
66,499
Relative Volume:
0.13
時価総額:
$910.65M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.39%
1か月 パフォーマンス:
+5.67%
6か月 パフォーマンス:
+16.11%
1年 パフォーマンス:
-29.60%
1日の値動き範囲:
Value
$15.42
$16.81
1週間の範囲:
Value
$15.42
$17.71
52週間の値動き範囲:
Value
$7.80
$28.09

Bicara Therapeutics Inc Stock (BCAX) Company Profile

Name
名前
Bicara Therapeutics Inc
Name
セクター
Healthcare (1141)
Name
電話
617-468-4219
Name
住所
116 HUNTINGTON AVENUE SUITE 703, BOSTON
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
BCAX's Discussions on Twitter

BCAX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
BCAX
Bicara Therapeutics Inc
16.69 867.25M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.60 106.97B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
660.79 68.62B 14.25B 4.58B 3.56B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
445.23 63.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
805.73 50.61B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
187.46 35.29B 398.11M -1.03B -868.57M -5.7032

Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-19 開始されました Piper Sandler Overweight
2025-05-23 アップグレード Wells Fargo Underweight → Equal Weight
2025-04-17 開始されました Wells Fargo Underweight
2025-02-06 開始されました Wedbush Outperform
2024-12-06 開始されました H.C. Wainwright Buy
2024-11-05 開始されました Rodman & Renshaw Buy
2024-10-08 開始されました Cantor Fitzgerald Overweight
2024-10-08 開始されました Morgan Stanley Overweight
2024-10-08 開始されました Stifel Buy
2024-10-08 開始されました TD Cowen Buy
すべてを表示

Bicara Therapeutics Inc (BCAX) 最新ニュース

pulisher
07:01 AM

How Bicara Therapeutics Inc. stock benefits from global expansionBond Market & Capital Protection Trading Alerts - newser.com

07:01 AM
pulisher
04:44 AM

Is Bicara Therapeutics Inc. stock resilient to inflationWeekly Stock Summary & Short-Term Trading Opportunity Alerts - newser.com

04:44 AM
pulisher
04:25 AM

What risks investors should watch in Bicara Therapeutics Inc. stockEarnings Growth Report & Safe Capital Growth Tips - newser.com

04:25 AM
pulisher
01:48 AM

Is Bicara Therapeutics Inc. stock safe for conservative investors2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com

01:48 AM
pulisher
Oct 29, 2025

Why Bicara Therapeutics Inc. stock is considered a top pickWeekly Trend Recap & Real-Time Buy Signal Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Will Bicara Therapeutics Inc. stock benefit from automationGlobal Markets & Consistent Profit Trading Strategies - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How Bicara Therapeutics Inc. stock compares to market leadersEarnings Summary Report & Breakout Confirmation Trade Signals - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Real time alert setup for Bicara Therapeutics Inc. performance2025 Trade Ideas & Stepwise Trade Signal Implementation - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How institutional buying supports Bicara Therapeutics Inc. stockPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Is Bicara Therapeutics Inc. stock a contrarian buyWeekly Trade Review & Detailed Earnings Play Strategies - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

What institutional flow reveals about Bicara Therapeutics Inc.Earnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Bicara Therapeutics Inc. stock see insider buyingEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Bicara Therapeutics Inc. stock a buy before product launches2025 Technical Overview & Growth Focused Stock Reports - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Bicara Therapeutics’ FORTIFI-HN01 Study: A Promising Step in Cancer Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Bicara Therapeutics’ Innovative Approach to EGFR-Driven Tumors: A Clinical Study Update - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology - Benzinga

Oct 27, 2025

Bicara Therapeutics Inc (BCAX) 財務データ

Bicara Therapeutics Inc (BCAX) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Bicara Therapeutics Inc (BCAX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Cohlhepp Ryan
President and COO
Oct 15 '25
Sale
18.16
12,500
226,942
198,141
$37.12
price up icon 1.26%
$28.54
price down icon 1.52%
$93.98
price up icon 4.21%
$105.28
price up icon 1.61%
biotechnology ONC
$311.39
price down icon 0.89%
$186.81
price up icon 12.27%
大文字化:     |  ボリューム (24 時間):